Woodline Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.3M | Buy |
|
|||||
|
2023
Q3 | $3.33M | Buy |
|
|||||
|
2023
Q2 | $4.34M | Buy |
|
|||||
|
2023
Q1 | $4.42M | Buy |
|
|||||
|
2022
Q4 | $3.5M | Sell |
|
|||||
|
2022
Q3 | $4.85M | Buy |
|
|||||
|
2022
Q2 | $5.12M | Buy |
|
|||||
|
2022
Q1 | $6.7M | Hold |
|
|||||
|
2021
Q4 | $5.28M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $10.5M | Buy |
|
|||||
|
2020
Q1 | $6.45M | Sell |
|
|||||
|
2019
Q4 | $17.7M | Buy |
|